BeiGene, Ltd. (NASDAQ:BGNE) announced on 7/27/18 a Hong Kong initial public offering and a global offering (the “Offering”) of 65,600,000 of its ordinary shares and the proposed listing of the Shares on the Main Board of The Stock Exchange of Hong Kong Limited (the “SEHK”). BeiGene’s American Depositary Shares (“ADS”) are currently listed on the Nasdaq Global Select Market under the symbol “BGNE.” Each ADS represents the right to receive 13 ordinary shares.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,